Healthcare for patients with cancer and rare diseases is too expensive.
Paula Bickley presents at PBMI Specialty Rx Forum on putting patients first.
Biologics seamlessly integrates with hospitals to get patients on their oncology or rare disease therapy faster.
The COVID-19 pandemic has upended virtually every aspect of healthcare.
Paula Bickley talks with Peter Wehrwein about maintaining patient-centeredness.
Specialty pharmacies can play an integral part in supporting patients during these times of uncertainty.
Recommendations for optimizing success on treatment for patients with chronic lymphocytic leukemia (CLL).
How MRD (minimum residual disease) testing affects the use of limited duration therapy
Trials focusing on patient populations with newly diagnosed chronic lymphocytic leukemia (CLL).